drugset / Trial / NCT03921073
Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma
NaSingle-groupOpen-labelTreatment
Summary
This is a single-arm study evaluating the efficacy of injecting Talimogene Laherparepvec T-VEC into Cutaneous Angiosarcoma tumors.
Timeline
- Start
- 2019-08-20
- Primary completion
- 2021-09-28
- Completion
- 2021-09-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Talimogene Laherparepvec | Other / unclassified | 4 ml | Other |